Methods of treating cardiomyopathy using prkag2-targeting antibody-oligonucleotide conjugates

TW202633666APending Publication Date: 2026-08-16ATRIUM THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114143616
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-07-31
Filing Date
2025-11-07
Publication Date
2026-08-16

Smart Images

  • Figure TWG2TA001072948_001
    Figure TWG2TA001072948_001
  • Figure TWG2TA001072948_002
    Figure TWG2TA001072948_002
  • Figure TWG2TA001072948_003
    Figure TWG2TA001072948_003
Patent Text Reader

Abstract

Disclosed herein are methods of treating cardiomyopathy or modulating PRKAG2 expression or activity in the cardiac muscle tissues using pharmaceutical compositions, of PRKAG2 antibody oligonucleotide conjugates (AOC).
Need to check novelty before this filing date? Find Prior Art